Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding Study of sIPV vs cIPV in Healthy Infants
NCT03566940Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2018
- Primary completion
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis, sponsored by Janssen Pharmaceutical. Started Jul 2018; status: completed.
02
Drugs
Sabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT03566940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03566940.